No association between the brain-derived neurotrophic factor gene and schizophrenia in a Japanese population

Schizophrenia Research

Volumn 84, Issue 1, 2006, Pages 29-35

  Watanabe, Yuichiro ^a   Muratake, Tatsuyuki ^a,b   Kaneko, Naoshi ^a   Nunokawa, Ayako ^a   Someya, Toshiyuki ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Brain derived neurotrophic factor; Case control study; Schizophrenia; Single nucleotide polymorphism

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; DNA POLYMORPHISM; ETHNIC GROUP; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 33747502544     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2006.03.011     Document Type: Article

References (45)

1. Anttila S., Illi A., Kampman O., Mattila K.M., Lehtimäki T., and Leinonen E. Lack of association between two polymorphisms of brain-derived neurotrophic factor and response to typical neuroleptics. J. Neural Transm. 112 (2005) 885-890
2. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.-F., and Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry 50 (2001) 260-265
3. Chen Q.-Y., Chen Q., Feng G.-Y., Wan C.-L., Lindpaintner K., Wang L.-J., Chen Z.-X., Gao Z.-S., Tang J.-S., Li X.-W., and He L. Association between the brain-derived neurotrophic factor (BDNF) gene and schizophrenia in the Chinese population. Neurosci. Lett. 397 (2006) 285-290
4. de Krom M., Bakker S.C., Hendriks J., van Elburg A., Hoogendoorn M., Verduijn W., Sinke R., Kahn R., and Adan R.A.H. Polymorphisms in the brain-derived neurotrophic factor gene are not associated with either anorexia nervosa or schizophrenia in Dutch patients. Psychiatr. Genet. 15 (2005) 81
5. 66 met genotype and episodic memory. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 134B (2005) 73-75
6. Durany N., Michel T., Zöchling R., Boissl K.W., Cruz-Sánchez F.F., Riederer P., and Thome J. Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr. Res. 52 (2001) 79-86
7. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., and Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 (2003) 257-269
8. Fanous A.H., Neale M.C., Straub R.E., Webb B.T., O'Neill A.F., and Walsh D. Clinical features of psychotic disorders and polymorphisms in HT2A, DRD2, DRD4, SLC6A3 (DAT1), and BDNF: a family based association study. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 125B (2004) 69-78
9. 270T polymorphisms in schizophrenia: a case-control study. Schizophr. Res. 73 (2005) 27-30
10. Gourion D., Goldberger C., Leroy S., Bourdel M.-C., Olié J.-P., and Krebs M.-O. Age at onset of schizophrenia: interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants. Neuroreport 16 (2005) 1407-1410
11. Hashimoto T., Bergen S.E., Nguyen Q.L., Xu B., Monteggia L.M., Pierri J.N., Sun Z., Sampson A.R., and Lewis D.A. Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J. Neurosci. 25 (2005) 372-383
12. Hawi Z., Straub R.E., O'Neill A., Kendler K.S., Walsh D., and Gill M. No linkage or linkage disequilibrium between brain-derived neurotrophic factor (BDNF) dinucleotide repeat polymorphism and schizophrenia in Irish families. Psychiatry Res. 81 (1998) 111-116
13. Hong C.-J., Yu Y.W.-Y., Lin C.-H., and Tsai S.-J. An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neurosci. Lett. 349 (2003) 206-208
14. Iritani S., Niizato K., Nawa H., Ikeda K., and Emson P.C. Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains. Prog. Neuro-psychopharmacol. Biol. Psychiatry 27 (2003) 801-807
15. Itoh K., Hashimoto K., Shimizu E., Sekine Y., Ozaki N., Inada T., Harano M., Iwata N., Komiyama T., Yamada M., Sora I., Nakata K., Ujike H., and Iyo M. Association study between brain-derived neurotrophic factor gene and methamphetamine abusers in Japan. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 132B (2005) 70-73
16. Jockers-Scherübl M.C., Danker-Hopfe H., Mahlberg R., Selig F., Rentzsh J., Schürer F., Lang U.E., and Hellweg R. Brain-derived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse. Neurosci. Lett. 371 (2004) 79-83
17. Knable M.B., Barci B.M., Webster M.J., Meador-Woodruff J., and Torrey E.F. Molecular abnormalities of the hippocampus in severe psychotic illness: postmortem findings from the Stanley Neuropathology Consortium. Mol. Psychiatry 9 (2004) 609-620
18. Knüsel B., Winslow J.W., Rosenthal A., Burton L.E., Seid D.P., Nikolics K., and Hefti F. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 961-965
19. Koizumi H., Hashimoto K., Shimizu E., Iyo M., Mashimo Y., and Hata A. Further analysis of microsatellite marker in the BDNF gene. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 135B (2005) 103
20. Korte M., Carroll P., Wolf E., Brem G., Thoenen H., and Bonhoeffer T. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 8856-8860
21. Krebs M.O., Guillin O., Bourdel M.C., Schwartz J.C., Olie J.P., Poirier M.F., and Sokoloff P. Brain Derived Neurotrophic Factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia. Mol. Psychiatry 5 (2000) 558-562
22. Kunugi H., Ueki A., Otsuka M., Isse K., Hirasawa H., Kato N., Nabika T., Kobayashi S., and Nanko S. A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease. Mol. Psychiatry 6 (2001) 83-86
23. Mizuno K., Carnahan J., and Nawa H. Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons. Dev. Biol. 165 (1994) 243-256
24. Mizuno M., Yamada K., Olariu A., Nawa H., and Nabeshima T. Involvement of brain-derived neurotrophic factor in spatial memory formation and maintenance in a radial arm maze test in rats. J. Neurosci. 20 (2000) 7116-7121
25. Muglia P., Vicente A.M., Verga M., King N., Macciardi F., and Kennedy J.L. Association between the BDNF gene and schizophrenia. Mol. Psychiatry 8 (2003) 147-148
26. Nanko S., Kunigi H., Hirasawa H., Kato N., Nabika T., and Kobayashi S. Brain-derived neurotrophic factor gene and schizophrenia: polymorphism screening and association analysis. Schizophr. Res. 62 (2003) 281-283
27. Nawa H., Takahashi M., and Patterson P.H. Cytokine and growth factor involvement in schizophrenia-support for the developmental model. Mol. Psychiatry 5 (2000) 594-603
28. Neves-Pereira M., Cheung J.K., Pasdar A., Zhang F., Breen G., Yates P., Sinclair M., Crombie C., Walker N., and Clair D.M.S. BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol. Psychiatry 10 (2005) 208-212
29. Pi{dotless}ri{dotless}ldar S., Gönül A.A., Taneli F., and Akdeniz F. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment. Prog. Neuro-psychopharmacol. Biol. Psychiatry 28 (2004) 709-713
30. Purcell S., Cherny S.S., and Sham P.C. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19 (2003) 149-150
31. Rosa A., Cuesta M.J., Fatjó-Vilas M., Peralta V., Zarzuela A., and Fañanás L. The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis: evidence from a family-based association study. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 141B (2006) 135-138
32. Sasaki T., Dai X.-Y., Kuwata S., Fukuda R., Kunugi H., Hattori M., and Nanko S. Brain-derived neurotrophic factor gene and schizophrenia in Japanese subjects. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 74 (1997) 443-444
33. Schumacher J., Jamra R.A., Becker T., Ohlraun S., Klopp N., Binder E.B., Schulze T.G., Deschner M., Schmäl C., Höfels S., Zobel A., Illig T., Propping P., Holsboer F., Rietschel M., Nöthen M.M., and Cichon S. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol. Psychiatry 58 (2005) 307-314
34. Shimizu E., Hashimoto K., Watanabe H., Komatsu N., Okamura N., Koike K., Shinoda N., Nakazato M., Kumakiri C., Okada S., and Iyo M. Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls. Neurosci. Lett. 351 (2003) 111-114
35. Szczepankiewicz A., Skibinska M., Czerski P.M., Kapelski P., Leszczynska-Rodziewicz A., Slopien A., Dmitrzak-Wêglarz M., Rybakowski F., Rybakowski J., and Hauser J. No association of the brain-derived neurotrophic factor (BDNF) gene C-270T polymorphism with schizophrenia. Schizophr. Res. 76 (2005) 187-193
36. Szekeres G., Juhász A., Rimanóczy A., Kéri S., and Janka Z. The C270T polymorphism of the brain-derived neurotrophic factor gene is associated with schizophrenia. Schizophr. Res. 65 (2003) 15-18
37. Szeszko P.R., Lipsky R., Mentschel C., Robinson D., Gunduz-Bruce H., Sevy S., Ashtari M., Napolitano B., Bilder R.M., Kane J.M., Goldman D., and Malhotra A.K. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol. Psychiatry 10 (2005) 631-636
38. Takahasi M., Shirakawa O., Toyooka K., Kitamura N., Hashimoto T., Maeda K., Koizumi M., Wakabayashi K., Takahashi H., Someya T., and Nawa H. Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Mol. Psychiatry 5 (2000) 293-300
39. Tan Y.L., Zhou D.F., Cao L.Y., Zou Y.Z., Wu G.Y., and Zhang X.Y. Effect of the BDNF Val66Met genotype on episodic memory in schizophrenia. Schizophr. Res. 77 (2005) 355-356
40. Tan Y.L., Zhou D.F., Cao L.Y., Zou Y.Z., and Zhang X.Y. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics. Neurosci. Lett. 382 (2005) 27-32
41. Tan Y.L., Zhou D.F., and Zhang X.Y. Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements. Schizophr. Res. 74 (2005) 263-270
42. Toyooka K., Asama K., Watanabe Y., Muratake T., Takahashi M., Someya T., and Nawa H. Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res. 110 (2002) 249-257
43. Virgos C., Martorell L., Valero J., Figuera L., Civeira F., Joven J., Labad A., and Vilella E. Association study of schizophrenia with polymorphisms at six candidate genes. Schizophr. Res. 49 (2001) 65-71
44. Wassink T.H., Nelson J.J., Crowe R.R., and Andreasen N.C. Heritability of BDNF alleles and their effect on brain morphology in schizophrenia. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 88 (1999) 724-728
45. Weickert C.S., Hyde T.M., Lipska B.K., Herman M.M., Weinberger D.R., and Kleinman J.E. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol. Psychiatry 8 (2003) 529-610